At Penn Medicine's Abramson Cancer Center, patients with anal cancer receive their care from a multidisciplinary team of nationally recognized experts in the diagnosis, treatment and research of gastrointestinal cancer.
The anus is at the end of the digestive tract below the rectum. The anal canal is a three- to four-centimeter long structure between the anal sphincter, a muscle that controls bowel continence, and the anal margin, the area of skin just outside of the digestive tract. The anus is the opening of the rectum to the outside of the body.
There are two types of anal cancer:
Anal cancer is not very common and accounts for only 1 to 2 percent of all gastrointestinal cancers.
Penn Medicine's multidisciplinary approach to cancer diagnosis and treatment provides better outcomes and gives patients access to the most advanced treatment, surgical techniques and clinical trials. This multidisciplinary approach has a dual goal of anal conservation and cure of disease.
Because navigating a cancer diagnosis and treatment options can be difficult, patients who wish to connect with a cancer specialist at Penn Medicine can speak with a cancer nurse, who can help them make an appointment with the right physician.
To connect with a cancer nurse at Penn Medicine, patients should call 800-789-PENN (7366).
Risk factors can increase the chance of getting cancer. There are different kinds of risk factors. Some risk factors for cancer, like age and family history, cannot be prevented.
Patients who feel they are at risk may benefit from consulting with a risk assessment specialist within Penn Medicine's GI genetics program at the Abramson Cancer Center.
Risk factors affect the chance of getting anal cancer. Having a risk factor, or even several, does not always mean that someone will get cancer.
While cancer cannot be totally prevented, a person's risk for anal cancer may decrease significantly with preventative measures.
Cancer of the anal margin is cancer that is found just outside of the anus – on the skin. This type of cancer is usually treated in the same way skin cancer is treated – with surgery, excising the lesion, but not the anus itself.
Cancer of the anal margin should not be confused with melanoma of the anus.
Cancer in the anal canal cannot be detected by sight. Anal canal cancer is usually detected with a digital rectal exam or a proctoscopy.
Many cases of anal cancer can be found early because the cancer forms in an area that physicians can see and reach easily. This is why it is important to have regular check-ups.
Anal cancer can be mistaken for hemorrhoids because some symptoms are similar.
Some symptoms of anal cancer include:
Staging systems provide doctors with a common language for describing tumors. After cancer is first diagnosed, a series of tests are used to investigate the extent of the cancer and to see whether it has spread to other parts of the body from where it started. Staging is a way of recording the size and growth of a cancer, and determining the plan for treatment. By understanding the stage of their cancer, patients can make informed decisions about their treatment.
Staging anal cancer attempts to discover the following:
After being diagnosed with anal cancer, patients at the Abramson Cancer Center may be evaluated through the Gastrointestinal Cancer Evaluation Center (GICEC). The center provides patients with expert support and evaluation to discuss treatment options and individualized treatment plans.
Patients with anal cancer are treated by a multidisciplinary team of cancer specialists who see more patients with gastrointestinal (GI) cancers in one year than many doctors see in their careers.
The physicians of Penn Medicine's GI cancer program are nationally recognized for their expertise in the diagnosis and treatment of cancer. Patients with anal cancer are treated by Penn surgeons in the Division of Colon and Rectal Surgery.
Penn's GI cancer treatment team includes:
Penn's GI cancer program is also supported by a robust research program with immediate translation from bench to bedside.
Patients at Penn Medicine can benefit from participating in clinical trials. Patients interested in learning more about clinical trials should speak with a member of their treatment team.
An accurate cancer diagnosis from trusted cancer specialists is the first step in getting personalized treatment options to treat anal cancer.
Patients who choose Penn's Abramson Cancer Center, benefit from a multidisciplinary team of cancer specialists including medical oncologists, gastroenterologists, radiologists, pathologists and surgeons who work together to provide a diagnosis and treatment plan designed specifically for each patient with anal cancer.
Cancer specialists at Penn Medicine are highly experienced in using the most advanced techniques for diagnosing anal cancer.
Navigating a cancer diagnosis and treatment options can be difficult. Patients who wish to connect with a cancer specialist at Penn Medicine can speak with a cancer nurse who can help them make an appointment with the right person. Penn Medicine’s contact center has experienced cancer nurses available and ready to guide patients in finding the cancer specialist right for them.
To connect with a cancer nurse at Penn Medicine, patients should call 800-789-PENN (7366).
Currently, there are no recommendations for screening the general public for anal cancer, such as mammograms for breast cancer or colonoscopies for colon cancer. However, people who are at increased risk for anal cancer should talk to their physicians about anal cancer screening
Those at increased risk include HIV-positive men, men who have sex with men, individuals with multiple sexual partners and women with a history of cervical warts or precancerous changes identified in the cervix.
Anal cancer can either be seen if it is on the anal skin or if it is within the anal canal. If a physician suspects anal cancer, he may perform or order one or more of these tests to diagnose and stage anal cancer.
Staging anal cancer attempts to discover the following:
Staging is a way of describing a cancer, such as where it is located, if or where it has spread, and if it is affecting the functions of other organs in the body. Doctors use diagnostic tests to determine the cancer's stage, so staging may not be complete until all the tests are finished. Knowing the stage helps the doctor to decide what kind of treatment is best and can help predict a patient's chance of recovery.
Following the diagnosis and staging of anal cancer, cancer specialists at Penn Medicine’s Abramson Cancer Center develop a personalized treatment plan.
Anal margin cancer, otherwise known as “perianal cancer” is treated with surgery to remove the growth.
Anal canal cancer is usually treated with a combination of chemotherapy and radiation. Surgery is rarely needed in cases of anal canal cancer.
In all cases of anal cancer, Penn cancer specialists are committed to doing everything they can to conserve the anus and anal tissue.
Penn’s treatment options for anal margin cancer include:
Penn’s treatment options for anal canal cancer include:
Other possible treatment options for anal margin and canal cancer include:
Because navigating a cancer diagnosis and treatment options can be difficult, patients who wish to connect with a cancer specialist at Penn Medicine can speak with a cancer nurse, who can help them make an appointment with the right physician.
To connect with a cancer nurse at Penn Medicine, patients should call 800-789-PENN (7366).
Penn medicine offers patients one of the most advanced colorectal surgery programs in the United States with a nationally recognized record for high-quality patient care and survivorship.
Local resection surgery for anal margin cancer, or cancer that can be seen on the outside of the anus, is generally the first treatment if the cancer is located on the skin surrounding the anus and can be completely removed with surgery. Typically, if the tumor is removed completely, no further treatment is required. Close surveillance and follow-up with the surgeon and medical oncologist are needed to ensure that rare recurrences are detected early.
Local resection is a surgical procedure in which the tumor is cut from the skin around the anus along with some of the surrounding healthy tissue. Local resection may be used if the cancer is small and has not spread. This procedure saves the sphincter muscles and anus so the patient can still control bowel movements. This surgery is used for anal margin cancers.
Radiation oncologists at Penn Medicine are recognized for techniques that target radiation precisely to the disease site while sparing nearby tissue.
Proton therapy at Penn Medicine is now being used to treat upper gastrointestinal cancers and recurrent tumors in the digestive tract. Penn Medicine is one of the only facilities in the country treating gastrointestinal cancers in this way.
Radiation therapy uses high-energy radiation to kill cancer cells. A radiation therapy schedule usually consists of a specific number of treatments given over an extended period of time. In many cases, radiation therapy is capable of killing all of the cancer cells.
Radiation therapy for anal cancer is commonly used first in combination with chemotherapy for anal canal cancer, or cancer that is inside the anal canal and cannot be seen. Anal canal cancer is very sensitive to chemotherapy and radiation treatments.
The imaging technology used by radiation oncologists at Penn Medicine helps shape the radiation treatment beam to the shape of the tumor. Known as conformal radiation therapy, this technology gives doctors more control when treating tumors.
In conformal radiation, a special computer uses CT imaging scans to create 3-D maps of the cancer’s location in the body. The system permits the delivery of radiation from several directions and the beams can then be shaped, or conformed, to match the shape of the cancer. Conformal radiation therapy limits radiation exposure to nearby healthy tissue as well as the tissue in the beam's path.
This advanced type of radiation therapy uses a computer-controlled device, called a linear accelerator, to deliver precise doses of radiation to tumors or specific areas within the tumors. Radiation therapy, including IMRT, stops cancer cells from dividing and growing, thus slowing or stopping tumor growth.
In many cases, radiation therapy is capable of killing all of the cancer cells. Using 3-D computed tomography (CT) images along with computerized dose calculations, IMRT allows for the radiation dose to conform more precisely to the shape of the tumor by controlling — or modulating — the intensity of the radiation beam. The therapy allows higher radiation doses to be delivered to areas within the tumor while minimizing the dose to the surrounding area.
Volumetric modulated arc therapy (VMAT) is a type of specialized intensity-modulated radiation therapy, or IMRT. VMAT delivers radiation by rotating the radiation machine, through one or more arcs while radiation is continuously delivered.
VMAT allows Penn radiation oncologists to treat complex cancers while minimizing exposure to surrounding healthy tissue. VMAT shortens radiation delivery time, and offers patients more comfort because it does not require them to lie completely still for long periods of time.
Penn radiation oncologists use RapidArc™ radiotherapy technology to treat hard to reach tumors.
Penn Medicine is the only health care facility in the country that is using proton therapy to treat recurrent gastrointestinal tumors in clinical trials.
Penn Medicine's Roberts Proton Therapy Center is the largest and most advanced facility in the world for this precise form of cancer radiation. Patients have access to one of the most sophisticated weapons against cancer, seamlessly integrated with the full range of oncology services available at Penn Medicine. Proton therapy is external beam radiotherapy in which protons are directed at a tumor.
The radiation dose that is given through protons is very precise, and limits the exposure of normal tissues. This allows the radiation dose delivered to the tumor to be increased beyond conventional radiation. The result is a better chance for curing cancer with fewer harmful side effects.
Proton therapy, like all forms of radiation therapy, works by aiming the energized particles, in this case protons, onto the target tumor. The particles damage the DNA of cells, ultimately causing their death. Unlike X-rays, protons can be manipulated to release most of their energy only when they reach their target. With more energy reaching the cancerous cells, more damage is administered by each burst of radiation.
Penn Medicine specializes in a team approach to cancer treatment with interdisciplinary care and innovative approaches that use chemotherapy to target tumors prior to and after surgery.
Chemotherapy uses drugs to kill cancer cells. It is delivered through the bloodstream, targeting cancer cells throughout the body. Chemotherapy is usually delivered intravenously through a catheter or orally by pill.
Chemoradiotherapy is the practice in which chemotherapy and radiation therapy are used simultaneously.
Local resection surgery for anal canal cancer is very rare. If surgery for anal canal cancer is needed, Penn Medicine offers patients one of the most advanced colorectal surgery programs in the United States with a nationally recognized record for high-quality patient care and survivorship.
Local resection surgery removes cancer and surrounding tissues from the anal canal.
Close surveillance and follow-up with the surgeon and medical oncologist is needed to ensure that rare recurrences are detected early.
Today, more and more people are surviving cancer. Clinical trials benefit patients by providing access to breakthrough therapies and treatments. These new advances in cancer treatment are occurring every day at Penn Medicine, giving patients hope that even greater discoveries lie ahead. Through clinical trials:
Penn Medicine is the only health care facility in the country that is using proton therapy to treat recurrent gastrointestinal tumors in clinical trials. Also, radiation oncologists at Penn Medicine will soon use proton therapy to treat gastrointestinal cancers in the upper digestive tract.
In addition to standard treatments and clinical trials, patients at Penn Medicine may wish to add additional therapies and treatments such as massage therapy, acupuncture and art therapy. These therapies do not have curative intent, and are designed to complement standard treatments – not take their place.
At Penn Medicine, integrative medicine and wellness services can supplement traditional cancer treatments such as chemotherapy, surgery and radiation therapy. While conventional medicine plays a critical role in eradicating cancer, integrative medicine and wellness programs offer patients and their families ways to enhance the quality of their lives, minimize or reduce the side effects of cancer and cancer treatment, and promote healing and recovery.
The physicians at Penn Medicine are knowledgeable and supportive of complementary cancer treatments. The cancer team works with patients and families to integrate these supportive programs into the overall care plan, while ensuring the safety and health of patients.
The Abramson Cancer Center's range of integrative supportive services is designed to help patients cope with the cancer experience and improve their overall sense of well-being. Services include:
The Joan Karnell Cancer Center at Pennsylvania Hospital offers a variety of supportive care programs for patients and families, from diagnosis through survivorship. These programs are available at no cost to the patients treated at Pennsylvania Hospital, and some are open to patients treated elsewhere. These services include social work counseling, nutrition counseling, psychological counseling and spiritual counseling.
The Cancer Appetite and Rehabilitation Clinic focuses on patients with loss of appetite and weight as well as deconditioning.
The Supportive Care Clinic helps to manage cancer-related symptoms. Integrative support programs include:
Support groups and educational programs are available at Pennsylvania Hospital throughout the year.
Palliative care provides medical and non-medical interventions to ease the symptoms of cancer and its treatment. Palliative care includes physical, emotional and spiritual care that can enhance the quality of life for cancer patients.
Palliative care can be used to complement traditional cancer therapies, or can be used to improve quality of life when curative therapies are no longer an option to treat symptoms.
Palliative care is an approach to patient care that can be integrated with curative therapies at any point from diagnosis to survivorship or end of life care.
Palliative care services include palliative chemotherapy, radiation therapy and surgery as well as psychological counseling, art therapy and support groups for patients and families. The goals of palliative care are to enhance the quality of life for cancer patients and their families, and provide emotional and spiritual support to enhance personal growth.
Palliative care services are offered at Pennsylvania Hospital, and at the Hospital of the University of Pennsylvania.
Penn Home Care and Hospice Services offers a full range of home health care needs by partnering three top-level home health care services under one roof:
Penn Home Care and Hospice Services provides an array of specialized therapies and medications for patients with cancer and cancer-related conditions
Survivorship programs at Penn Medicine are a distinct phase of anal cancer care and are designed to help patients transition from their cancer treatment routine to a post-cancer care lifestyle. There are more than 12 million cancer survivors living and thriving today as a result of advances in cancer treatment. However, cancer treatments can result in physical, emotional and financial complications long after the therapy is complete.
Anal cancer has the highest rate of recurrence in the first one to two years after completing cancer treatment. It is important for patients to schedule follow-up visits with their physician as soon as their cancer treatment is completed.
At the end of treatment, anal cancer patients should schedule a survivorship visit with their oncologist and nurse practitioner. At this time, patients are provided with a summary of the treatment received as well as a plan for follow-up care.
Patients who have completed treatment for anal cancer can expect follow-up visits with their physician every three to four months for the first two years. A check of the anal area at the time of the office visit is routine.
Penn cancer providers work one-on-one with patients to develop survivorship care plans. Since every cancer is unique, the plans are tailored to the patients.
The survivorship care plan includes information on:
A survivorship care plan encourages patients to review the information with their health care team and become active participants in their follow-up care.
Penn also offers anal cancer patients a number of support programs and groups to enhance their survivorship care plans.
Penn Medicine’s Living Well After Cancer™ Program is a nationally recognized program that focuses on issues facing cancer survivors. The Abramson Cancer Center is a member of the LIVESTRONG™ Survivorship Center of Excellence Network. The program focuses on survivorship, a distinct phase of care.
Prescription for Living: The Cancer Survivorship Program at the Joan Karnell Cancer Center at Pennsylvania Hospital provides patients with a summary of important information about specific cancer diagnoses and treatments, as well as follow-up information and steps to take towards recovery, supportive care and education to help patients adjust to their lives as cancer survivors.
Penn offers cancer patients support programs and groups to enhance their survivorship care plans.
The Abramson Cancer Center hosts a wide range of materials and activities that provide education and support to address key areas of concern including survivorship for cancer patients and their loved ones.
Focus On: Gastrointestinal Cancers is a day-long conference that addresses issues for patients with anal cancer, as well as their loved ones.
It was on January 7th that Penn law student Brian Trainor, a healthy and active 31 year old with no known symptoms had a sudden seizure. Brian was rushed to HUP, where he received a CT scan and MRI, which uncovered a 2.5 centimeter tumor on the left frontal lobe of his brain.
Peter O'Dwyer, MD, professor of Hematology-Oncology and program director of Development Therapeutics in the Abramson Cancer Center, was interviewed on NBC10's 10! Show about Penn's work as part of the Stand Up to Cancer Dream Team... Read more